TRENDS AND PROSPECTS IN MEDICINAL AND PHARMA BIOTECHNOLOGIES IN EUROPE

Expected outcomes

Increased awareness and sharing of knowledge and experience on the key issues of pharma and medicinal biotechnologies and biobased industry, relevant to RIS3 strategy.
Briefing on the new technologies and their potential role to improve bioeconomy in the field of pharma and medicinal biotechnology and related industry.
Draft plan of join follow-up initiatives oriented on cooperative projects relevant to upcoming FP9 EC program period 2021-2027 discussed and drafted
Regional CEE network including research institutions and innovative high-tech companies in Med/Pharm BT constituted.